Representation, inclusion, and innovation: multidisciplinary explorations

por Lewis, Clayton, Carroll, John M
Publicado 2017

Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update

por Matiash, Kateryna, Lewis, Clayton S., Bogdanov, Vladimir Y.
Publicado 2021

Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640

por Lewis, Clayton S., Voelkel-Johnson, Christina, Smith, Charles D.
Publicado 2016

Activation of Carbonic Anhydrase IX by Alternatively Spliced Tissue Factor Under Late-Stage Tumor Conditions

por Ramchandani, Divya, Unruh, Dusten, Lewis, Clayton S., Bogdanov, Vladimir Y., Weber, Georg F.
Publicado 2016

Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease

por Lewis, Clayton S., Bari, Khurram, Xie, Changchun, Sherman, Kenneth E., Vasse, Marc, Van Dreden, Patrick, Bogdanov, Vladimir Y.
Publicado 2023

A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma

por Lewis, Clayton S., Karve, Aniruddha, Matiash, Kateryna, Stone, Timothy, Li, Jingxing, Wang, Jordon K., Versteeg, Henri H., Aronow, Bruce J., Ahmad, Syed A., Desai, Pankaj B., Bogdanov, Vladimir Y.
Publicado 2021

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

por Unruh, Dusten, Ünlü, Betül, Lewis, Clayton S., Qi, Xiaoyang, Chu, Zhengtao, Sturm, Robert, Keil, Ryan, Ahmad, Syed A., Sovershaev, Timofey, Adam, Mariette, Van Dreden, Patrick, Woodhams, Barry J., Ramchandani, Divya, Weber, Georg F., Rak, Janusz W., Wolberg, Alisa S., Mackman, Nigel, Versteeg, Henri H., Bogdanov, Vladimir Y.
Publicado 2016